|
NR 1-3/2007
|
|
|
|
|
|
|
|
|
Wpływ leczenia
przeciwzapalnego na powodzenie terapii zespołu suchego oka
The influence of
anti-inflammatory therapy on the treatment of Dry Eye Syndrome
Ewa Mrukwa-Kominek, Anna Rogowska-Godela,
Stanisława Gierek-Ciaciura
Z Katedry i Kliniki Okulistyki ¦l±skiej Akademii Medycznej
Kierownik: prof. dr hab. n. med. Ariadna Gierek-Łapińska |
|
|
| Summary: |
Dry eye syndrome is a
common chronic disease; agents and strategies for its
effective management are still lacking. The syndrome
tends to be accompanied by ocular surface inflammation;
therefore, the use of anti-inflammatory agents might
prove beneficial. The authors present up-to-date
guidelines, strategies, and efficacy of dry eye syndrome
management, including anti-inflammatory treatment.
As no diagnostic tests are now available to assess
ocular surface inflammation severity, the right timing
to launch an anti-inflammatory agent is difficult to
determine. Patients with mild intermittent bouts of
symptoms which can be alleviated with ophthalmic
lubricants do not typically require anti-inflammatory
therapy. The latter should be considered in those who do
not respond to lubricating drops, obtain poor results on
clinical tests, and show symptoms of ocular surface
irritation (eg. conjunctivae redness). Anti-inflammatory
treatment of dry eye syndrome may include short-term
corticosteroids, cyclosporine A emulsion, oral
tetracycline therapy, oral omega-3 fatty acid
supplements, and autologous serum eye drops.
Anti-inflammatory treatment should be safe and effective;
potential benefits should be evaluated for each
individual patient.
The authors have reviewed the advantages of
anti-inflammatory treatment in dry eye syndrome,
presented in literature. |
| Słowa kluczowe: |
suche oko, leczenie
przeciwzapalne, cyklospryna A, kwasy tłuszczowe,
androgeny, surowica własna. |
| Key words: |
dry eye, anti-inflammatory
treatment, cyclosporine A, fatty acids, androgens,
autologous serum eye drops. |
|
|
|
|
|
|
